Scientific publications

Aquaporin-7 and glycerol permeability as novel obesity drug-target pathways

Frühbeck G. [SP], Catalán V. [SP], Gómez-Ambrosi J. [SP], Rodríguez A.
Department of Endocrinology, Clínica Universitaria and Metabolic Research Laboratory, University of Navarra, c/Irunlarrea 1, 31008 Pamplona, Spain.

Magazine: Trends in Pharmacological Sciences

Date: Jul 1, 2006

Obesity Unit Endocrinology and Nutrition [SP]

Advances in determining the mechanisms that underlie the control of energy balance in mammals have recently been provided by the discovery and characterization of aquaporin-7 (AQP7), a water-glycerol transporter that is present in the plasma membrane of fat-storing cells (adipocytes).

Recent studies have shown that the absence of AQP7 expression in fat cells increases glycerol kinase activity, boosting triacylglycerol synthesis and ultimately leading to obesity. Thus, AQP7 operates as a glycerol channel in vivo, whereby adipocyte glycerol permeability has a key role in the regulation of fat accumulation.

CITATION  Trends Pharmacol Sci. 2006 Jul;27(7):345-7

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra